Medical Care
Global Nuclear Medicine Market Research Report 2024
- Jan 26, 24
- ID: 36106
- Pages: 87
- Figures: 170
- Views: 17
Nuclear Medicine,or Radiopharmaceuticals, are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The global Nuclear Medicine market was valued at US$ 6189.2 million in 2023 and is anticipated to reach US$ 10260 million by 2030, witnessing a CAGR of 7.4% during the forecast period 2024-2030.
North America is the largest consumption area, with a consumption market share nearly 50%. Following North America, Europe is the second place consumption region with the consumption market share of about 25%.
Global Nuclear Medicine key manufacturers include GE Healthcare, Bracco Imaging, etc. The global top 2 manufacturers account for over 30 percent of total share.
The classification of Nuclear Medicine includes Tc-99, I-123/131, In-111, Xe-133, Th-201 and Ga-67, and the proportion of Tc-99 is about 50%.
Nuclear Medicine is widely used in Diagnostic, Therapeutic. The most proportion of Nuclear Medicine is Diagnostic, and the market share is over 60%.
This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine.
Report Scope
The Nuclear Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nuclear Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nuclear Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Triad Isotopes
Nordion
Jubilant Pharma
Eli Lilly
SIEMENS
China Isotope & Radiation
Dongcheng
Segment by Type
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Others
Segment by Application
Diagnostic
Therapeutic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nuclear Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Nuclear Medicine market was valued at US$ 6189.2 million in 2023 and is anticipated to reach US$ 10260 million by 2030, witnessing a CAGR of 7.4% during the forecast period 2024-2030.
North America is the largest consumption area, with a consumption market share nearly 50%. Following North America, Europe is the second place consumption region with the consumption market share of about 25%.
Global Nuclear Medicine key manufacturers include GE Healthcare, Bracco Imaging, etc. The global top 2 manufacturers account for over 30 percent of total share.
The classification of Nuclear Medicine includes Tc-99, I-123/131, In-111, Xe-133, Th-201 and Ga-67, and the proportion of Tc-99 is about 50%.
Nuclear Medicine is widely used in Diagnostic, Therapeutic. The most proportion of Nuclear Medicine is Diagnostic, and the market share is over 60%.
This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine.
Report Scope
The Nuclear Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nuclear Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nuclear Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Triad Isotopes
Nordion
Jubilant Pharma
Eli Lilly
SIEMENS
China Isotope & Radiation
Dongcheng
Segment by Type
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Others
Segment by Application
Diagnostic
Therapeutic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nuclear Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nuclear Medicine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Tc-99
1.2.3 I-123/131
1.2.4 In-111
1.2.5 Xe-133
1.2.6 Th-201
1.2.7 Ga-67
1.2.8 Others
1.3 Market by Application
1.3.1 Global Nuclear Medicine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diagnostic
1.3.3 Therapeutic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nuclear Medicine Market Perspective (2019-2030)
2.2 Nuclear Medicine Growth Trends by Region
2.2.1 Global Nuclear Medicine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Nuclear Medicine Historic Market Size by Region (2019-2024)
2.2.3 Nuclear Medicine Forecasted Market Size by Region (2025-2030)
2.3 Nuclear Medicine Market Dynamics
2.3.1 Nuclear Medicine Industry Trends
2.3.2 Nuclear Medicine Market Drivers
2.3.3 Nuclear Medicine Market Challenges
2.3.4 Nuclear Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nuclear Medicine Players by Revenue
3.1.1 Global Top Nuclear Medicine Players by Revenue (2019-2024)
3.1.2 Global Nuclear Medicine Revenue Market Share by Players (2019-2024)
3.2 Global Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nuclear Medicine Revenue
3.4 Global Nuclear Medicine Market Concentration Ratio
3.4.1 Global Nuclear Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nuclear Medicine Revenue in 2023
3.5 Nuclear Medicine Key Players Head office and Area Served
3.6 Key Players Nuclear Medicine Product Solution and Service
3.7 Date of Enter into Nuclear Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nuclear Medicine Breakdown Data by Type
4.1 Global Nuclear Medicine Historic Market Size by Type (2019-2024)
4.2 Global Nuclear Medicine Forecasted Market Size by Type (2025-2030)
5 Nuclear Medicine Breakdown Data by Application
5.1 Global Nuclear Medicine Historic Market Size by Application (2019-2024)
5.2 Global Nuclear Medicine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Nuclear Medicine Market Size (2019-2030)
6.2 North America Nuclear Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Nuclear Medicine Market Size by Country (2019-2024)
6.4 North America Nuclear Medicine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nuclear Medicine Market Size (2019-2030)
7.2 Europe Nuclear Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Nuclear Medicine Market Size by Country (2019-2024)
7.4 Europe Nuclear Medicine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nuclear Medicine Market Size (2019-2030)
8.2 Asia-Pacific Nuclear Medicine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Nuclear Medicine Market Size by Region (2019-2024)
8.4 Asia-Pacific Nuclear Medicine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nuclear Medicine Market Size (2019-2030)
9.2 Latin America Nuclear Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Nuclear Medicine Market Size by Country (2019-2024)
9.4 Latin America Nuclear Medicine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nuclear Medicine Market Size (2019-2030)
10.2 Middle East & Africa Nuclear Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Nuclear Medicine Market Size by Country (2019-2024)
10.4 Middle East & Africa Nuclear Medicine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Detail
11.1.2 GE Healthcare Business Overview
11.1.3 GE Healthcare Nuclear Medicine Introduction
11.1.4 GE Healthcare Revenue in Nuclear Medicine Business (2019-2024)
11.1.5 GE Healthcare Recent Development
11.2 Bracco Imaging
11.2.1 Bracco Imaging Company Detail
11.2.2 Bracco Imaging Business Overview
11.2.3 Bracco Imaging Nuclear Medicine Introduction
11.2.4 Bracco Imaging Revenue in Nuclear Medicine Business (2019-2024)
11.2.5 Bracco Imaging Recent Development
11.3 Mallinckrodt
11.3.1 Mallinckrodt Company Detail
11.3.2 Mallinckrodt Business Overview
11.3.3 Mallinckrodt Nuclear Medicine Introduction
11.3.4 Mallinckrodt Revenue in Nuclear Medicine Business (2019-2024)
11.3.5 Mallinckrodt Recent Development
11.4 Lantheus Medical Imaging
11.4.1 Lantheus Medical Imaging Company Detail
11.4.2 Lantheus Medical Imaging Business Overview
11.4.3 Lantheus Medical Imaging Nuclear Medicine Introduction
11.4.4 Lantheus Medical Imaging Revenue in Nuclear Medicine Business (2019-2024)
11.4.5 Lantheus Medical Imaging Recent Development
11.5 Bayer
11.5.1 Bayer Company Detail
11.5.2 Bayer Business Overview
11.5.3 Bayer Nuclear Medicine Introduction
11.5.4 Bayer Revenue in Nuclear Medicine Business (2019-2024)
11.5.5 Bayer Recent Development
11.6 Triad Isotopes
11.6.1 Triad Isotopes Company Detail
11.6.2 Triad Isotopes Business Overview
11.6.3 Triad Isotopes Nuclear Medicine Introduction
11.6.4 Triad Isotopes Revenue in Nuclear Medicine Business (2019-2024)
11.6.5 Triad Isotopes Recent Development
11.7 Nordion
11.7.1 Nordion Company Detail
11.7.2 Nordion Business Overview
11.7.3 Nordion Nuclear Medicine Introduction
11.7.4 Nordion Revenue in Nuclear Medicine Business (2019-2024)
11.7.5 Nordion Recent Development
11.8 Jubilant Pharma
11.8.1 Jubilant Pharma Company Detail
11.8.2 Jubilant Pharma Business Overview
11.8.3 Jubilant Pharma Nuclear Medicine Introduction
11.8.4 Jubilant Pharma Revenue in Nuclear Medicine Business (2019-2024)
11.8.5 Jubilant Pharma Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Company Detail
11.9.2 Eli Lilly Business Overview
11.9.3 Eli Lilly Nuclear Medicine Introduction
11.9.4 Eli Lilly Revenue in Nuclear Medicine Business (2019-2024)
11.9.5 Eli Lilly Recent Development
11.10 SIEMENS
11.10.1 SIEMENS Company Detail
11.10.2 SIEMENS Business Overview
11.10.3 SIEMENS Nuclear Medicine Introduction
11.10.4 SIEMENS Revenue in Nuclear Medicine Business (2019-2024)
11.10.5 SIEMENS Recent Development
11.11 China Isotope & Radiation
11.11.1 China Isotope & Radiation Company Detail
11.11.2 China Isotope & Radiation Business Overview
11.11.3 China Isotope & Radiation Nuclear Medicine Introduction
11.11.4 China Isotope & Radiation Revenue in Nuclear Medicine Business (2019-2024)
11.11.5 China Isotope & Radiation Recent Development
11.12 Dongcheng
11.12.1 Dongcheng Company Detail
11.12.2 Dongcheng Business Overview
11.12.3 Dongcheng Nuclear Medicine Introduction
11.12.4 Dongcheng Revenue in Nuclear Medicine Business (2019-2024)
11.12.5 Dongcheng Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nuclear Medicine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Tc-99
1.2.3 I-123/131
1.2.4 In-111
1.2.5 Xe-133
1.2.6 Th-201
1.2.7 Ga-67
1.2.8 Others
1.3 Market by Application
1.3.1 Global Nuclear Medicine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diagnostic
1.3.3 Therapeutic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nuclear Medicine Market Perspective (2019-2030)
2.2 Nuclear Medicine Growth Trends by Region
2.2.1 Global Nuclear Medicine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Nuclear Medicine Historic Market Size by Region (2019-2024)
2.2.3 Nuclear Medicine Forecasted Market Size by Region (2025-2030)
2.3 Nuclear Medicine Market Dynamics
2.3.1 Nuclear Medicine Industry Trends
2.3.2 Nuclear Medicine Market Drivers
2.3.3 Nuclear Medicine Market Challenges
2.3.4 Nuclear Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nuclear Medicine Players by Revenue
3.1.1 Global Top Nuclear Medicine Players by Revenue (2019-2024)
3.1.2 Global Nuclear Medicine Revenue Market Share by Players (2019-2024)
3.2 Global Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nuclear Medicine Revenue
3.4 Global Nuclear Medicine Market Concentration Ratio
3.4.1 Global Nuclear Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nuclear Medicine Revenue in 2023
3.5 Nuclear Medicine Key Players Head office and Area Served
3.6 Key Players Nuclear Medicine Product Solution and Service
3.7 Date of Enter into Nuclear Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nuclear Medicine Breakdown Data by Type
4.1 Global Nuclear Medicine Historic Market Size by Type (2019-2024)
4.2 Global Nuclear Medicine Forecasted Market Size by Type (2025-2030)
5 Nuclear Medicine Breakdown Data by Application
5.1 Global Nuclear Medicine Historic Market Size by Application (2019-2024)
5.2 Global Nuclear Medicine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Nuclear Medicine Market Size (2019-2030)
6.2 North America Nuclear Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Nuclear Medicine Market Size by Country (2019-2024)
6.4 North America Nuclear Medicine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nuclear Medicine Market Size (2019-2030)
7.2 Europe Nuclear Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Nuclear Medicine Market Size by Country (2019-2024)
7.4 Europe Nuclear Medicine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nuclear Medicine Market Size (2019-2030)
8.2 Asia-Pacific Nuclear Medicine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Nuclear Medicine Market Size by Region (2019-2024)
8.4 Asia-Pacific Nuclear Medicine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nuclear Medicine Market Size (2019-2030)
9.2 Latin America Nuclear Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Nuclear Medicine Market Size by Country (2019-2024)
9.4 Latin America Nuclear Medicine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nuclear Medicine Market Size (2019-2030)
10.2 Middle East & Africa Nuclear Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Nuclear Medicine Market Size by Country (2019-2024)
10.4 Middle East & Africa Nuclear Medicine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Detail
11.1.2 GE Healthcare Business Overview
11.1.3 GE Healthcare Nuclear Medicine Introduction
11.1.4 GE Healthcare Revenue in Nuclear Medicine Business (2019-2024)
11.1.5 GE Healthcare Recent Development
11.2 Bracco Imaging
11.2.1 Bracco Imaging Company Detail
11.2.2 Bracco Imaging Business Overview
11.2.3 Bracco Imaging Nuclear Medicine Introduction
11.2.4 Bracco Imaging Revenue in Nuclear Medicine Business (2019-2024)
11.2.5 Bracco Imaging Recent Development
11.3 Mallinckrodt
11.3.1 Mallinckrodt Company Detail
11.3.2 Mallinckrodt Business Overview
11.3.3 Mallinckrodt Nuclear Medicine Introduction
11.3.4 Mallinckrodt Revenue in Nuclear Medicine Business (2019-2024)
11.3.5 Mallinckrodt Recent Development
11.4 Lantheus Medical Imaging
11.4.1 Lantheus Medical Imaging Company Detail
11.4.2 Lantheus Medical Imaging Business Overview
11.4.3 Lantheus Medical Imaging Nuclear Medicine Introduction
11.4.4 Lantheus Medical Imaging Revenue in Nuclear Medicine Business (2019-2024)
11.4.5 Lantheus Medical Imaging Recent Development
11.5 Bayer
11.5.1 Bayer Company Detail
11.5.2 Bayer Business Overview
11.5.3 Bayer Nuclear Medicine Introduction
11.5.4 Bayer Revenue in Nuclear Medicine Business (2019-2024)
11.5.5 Bayer Recent Development
11.6 Triad Isotopes
11.6.1 Triad Isotopes Company Detail
11.6.2 Triad Isotopes Business Overview
11.6.3 Triad Isotopes Nuclear Medicine Introduction
11.6.4 Triad Isotopes Revenue in Nuclear Medicine Business (2019-2024)
11.6.5 Triad Isotopes Recent Development
11.7 Nordion
11.7.1 Nordion Company Detail
11.7.2 Nordion Business Overview
11.7.3 Nordion Nuclear Medicine Introduction
11.7.4 Nordion Revenue in Nuclear Medicine Business (2019-2024)
11.7.5 Nordion Recent Development
11.8 Jubilant Pharma
11.8.1 Jubilant Pharma Company Detail
11.8.2 Jubilant Pharma Business Overview
11.8.3 Jubilant Pharma Nuclear Medicine Introduction
11.8.4 Jubilant Pharma Revenue in Nuclear Medicine Business (2019-2024)
11.8.5 Jubilant Pharma Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Company Detail
11.9.2 Eli Lilly Business Overview
11.9.3 Eli Lilly Nuclear Medicine Introduction
11.9.4 Eli Lilly Revenue in Nuclear Medicine Business (2019-2024)
11.9.5 Eli Lilly Recent Development
11.10 SIEMENS
11.10.1 SIEMENS Company Detail
11.10.2 SIEMENS Business Overview
11.10.3 SIEMENS Nuclear Medicine Introduction
11.10.4 SIEMENS Revenue in Nuclear Medicine Business (2019-2024)
11.10.5 SIEMENS Recent Development
11.11 China Isotope & Radiation
11.11.1 China Isotope & Radiation Company Detail
11.11.2 China Isotope & Radiation Business Overview
11.11.3 China Isotope & Radiation Nuclear Medicine Introduction
11.11.4 China Isotope & Radiation Revenue in Nuclear Medicine Business (2019-2024)
11.11.5 China Isotope & Radiation Recent Development
11.12 Dongcheng
11.12.1 Dongcheng Company Detail
11.12.2 Dongcheng Business Overview
11.12.3 Dongcheng Nuclear Medicine Introduction
11.12.4 Dongcheng Revenue in Nuclear Medicine Business (2019-2024)
11.12.5 Dongcheng Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Nuclear Medicine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Tc-99
Table 3. Key Players of I-123/131
Table 4. Key Players of In-111
Table 5. Key Players of Xe-133
Table 6. Key Players of Th-201
Table 7. Key Players of Ga-67
Table 8. Key Players of Others
Table 9. Global Nuclear Medicine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Nuclear Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Nuclear Medicine Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global Nuclear Medicine Market Share by Region (2019-2024)
Table 13. Global Nuclear Medicine Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global Nuclear Medicine Market Share by Region (2025-2030)
Table 15. Nuclear Medicine Market Trends
Table 16. Nuclear Medicine Market Drivers
Table 17. Nuclear Medicine Market Challenges
Table 18. Nuclear Medicine Market Restraints
Table 19. Global Nuclear Medicine Revenue by Players (2019-2024) & (US$ Million)
Table 20. Global Nuclear Medicine Market Share by Players (2019-2024)
Table 21. Global Top Nuclear Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine as of 2023)
Table 22. Ranking of Global Top Nuclear Medicine Companies by Revenue (US$ Million) in 2023
Table 23. Global 5 Largest Players Market Share by Nuclear Medicine Revenue (CR5 and HHI) & (2019-2024)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Nuclear Medicine Product Solution and Service
Table 26. Date of Enter into Nuclear Medicine Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Nuclear Medicine Market Size by Type (2019-2024) & (US$ Million)
Table 29. Global Nuclear Medicine Revenue Market Share by Type (2019-2024)
Table 30. Global Nuclear Medicine Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 31. Global Nuclear Medicine Revenue Market Share by Type (2025-2030)
Table 32. Global Nuclear Medicine Market Size by Application (2019-2024) & (US$ Million)
Table 33. Global Nuclear Medicine Revenue Market Share by Application (2019-2024)
Table 34. Global Nuclear Medicine Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 35. Global Nuclear Medicine Revenue Market Share by Application (2025-2030)
Table 36. North America Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Nuclear Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Nuclear Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Europe Nuclear Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 41. Europe Nuclear Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 42. Asia-Pacific Nuclear Medicine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 43. Asia-Pacific Nuclear Medicine Market Size by Region (2019-2024) & (US$ Million)
Table 44. Asia-Pacific Nuclear Medicine Market Size by Region (2025-2030) & (US$ Million)
Table 45. Latin America Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Latin America Nuclear Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 47. Latin America Nuclear Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 48. Middle East & Africa Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 49. Middle East & Africa Nuclear Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 50. Middle East & Africa Nuclear Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 51. GE Healthcare Company Detail
Table 52. GE Healthcare Business Overview
Table 53. GE Healthcare Nuclear Medicine Product
Table 54. GE Healthcare Revenue in Nuclear Medicine Business (2019-2024) & (US$ Million)
Table 55. GE Healthcare Recent Development
Table 56. Bracco Imaging Company Detail
Table 57. Bracco Imaging Business Overview
Table 58. Bracco Imaging Nuclear Medicine Product
Table 59. Bracco Imaging Revenue in Nuclear Medicine Business (2019-2024) & (US$ Million)
Table 60. Bracco Imaging Recent Development
Table 61. Mallinckrodt Company Detail
Table 62. Mallinckrodt Business Overview
Table 63. Mallinckrodt Nuclear Medicine Product
Table 64. Mallinckrodt Revenue in Nuclear Medicine Business (2019-2024) & (US$ Million)
Table 65. Mallinckrodt Recent Development
Table 66. Lantheus Medical Imaging Company Detail
Table 67. Lantheus Medical Imaging Business Overview
Table 68. Lantheus Medical Imaging Nuclear Medicine Product
Table 69. Lantheus Medical Imaging Revenue in Nuclear Medicine Business (2019-2024) & (US$ Million)
Table 70. Lantheus Medical Imaging Recent Development
Table 71. Bayer Company Detail
Table 72. Bayer Business Overview
Table 73. Bayer Nuclear Medicine Product
Table 74. Bayer Revenue in Nuclear Medicine Business (2019-2024) & (US$ Million)
Table 75. Bayer Recent Development
Table 76. Triad Isotopes Company Detail
Table 77. Triad Isotopes Business Overview
Table 78. Triad Isotopes Nuclear Medicine Product
Table 79. Triad Isotopes Revenue in Nuclear Medicine Business (2019-2024) & (US$ Million)
Table 80. Triad Isotopes Recent Development
Table 81. Nordion Company Detail
Table 82. Nordion Business Overview
Table 83. Nordion Nuclear Medicine Product
Table 84. Nordion Revenue in Nuclear Medicine Business (2019-2024) & (US$ Million)
Table 85. Nordion Recent Development
Table 86. Jubilant Pharma Company Detail
Table 87. Jubilant Pharma Business Overview
Table 88. Jubilant Pharma Nuclear Medicine Product
Table 89. Jubilant Pharma Revenue in Nuclear Medicine Business (2019-2024) & (US$ Million)
Table 90. Jubilant Pharma Recent Development
Table 91. Eli Lilly Company Detail
Table 92. Eli Lilly Business Overview
Table 93. Eli Lilly Nuclear Medicine Product
Table 94. Eli Lilly Revenue in Nuclear Medicine Business (2019-2024) & (US$ Million)
Table 95. Eli Lilly Recent Development
Table 96. SIEMENS Company Detail
Table 97. SIEMENS Business Overview
Table 98. SIEMENS Nuclear Medicine Product
Table 99. SIEMENS Revenue in Nuclear Medicine Business (2019-2024) & (US$ Million)
Table 100. SIEMENS Recent Development
Table 101. China Isotope & Radiation Company Detail
Table 102. China Isotope & Radiation Business Overview
Table 103. China Isotope & Radiation Nuclear Medicine Product
Table 104. China Isotope & Radiation Revenue in Nuclear Medicine Business (2019-2024) & (US$ Million)
Table 105. China Isotope & Radiation Recent Development
Table 106. Dongcheng Company Detail
Table 107. Dongcheng Business Overview
Table 108. Dongcheng Nuclear Medicine Product
Table 109. Dongcheng Revenue in Nuclear Medicine Business (2019-2024) & (US$ Million)
Table 110. Dongcheng Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nuclear Medicine Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Nuclear Medicine Market Share by Type: 2023 VS 2030
Figure 3. Tc-99 Features
Figure 4. I-123/131 Features
Figure 5. In-111 Features
Figure 6. Xe-133 Features
Figure 7. Th-201 Features
Figure 8. Ga-67 Features
Figure 9. Others Features
Figure 10. Global Nuclear Medicine Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Nuclear Medicine Market Share by Application: 2023 VS 2030
Figure 12. Diagnostic Case Studies
Figure 13. Therapeutic Case Studies
Figure 14. Nuclear Medicine Report Years Considered
Figure 15. Global Nuclear Medicine Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Nuclear Medicine Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Nuclear Medicine Market Share by Region: 2023 VS 2030
Figure 18. Global Nuclear Medicine Market Share by Players in 2023
Figure 19. Global Top Nuclear Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Nuclear Medicine Revenue in 2023
Figure 21. North America Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Nuclear Medicine Market Share by Country (2019-2030)
Figure 23. United States Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Nuclear Medicine Market Share by Country (2019-2030)
Figure 27. Germany Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Nuclear Medicine Market Share by Region (2019-2030)
Figure 35. China Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Nuclear Medicine Market Share by Country (2019-2030)
Figure 43. Mexico Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Nuclear Medicine Market Share by Country (2019-2030)
Figure 47. Turkey Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. GE Healthcare Revenue Growth Rate in Nuclear Medicine Business (2019-2024)
Figure 50. Bracco Imaging Revenue Growth Rate in Nuclear Medicine Business (2019-2024)
Figure 51. Mallinckrodt Revenue Growth Rate in Nuclear Medicine Business (2019-2024)
Figure 52. Lantheus Medical Imaging Revenue Growth Rate in Nuclear Medicine Business (2019-2024)
Figure 53. Bayer Revenue Growth Rate in Nuclear Medicine Business (2019-2024)
Figure 54. Triad Isotopes Revenue Growth Rate in Nuclear Medicine Business (2019-2024)
Figure 55. Nordion Revenue Growth Rate in Nuclear Medicine Business (2019-2024)
Figure 56. Jubilant Pharma Revenue Growth Rate in Nuclear Medicine Business (2019-2024)
Figure 57. Eli Lilly Revenue Growth Rate in Nuclear Medicine Business (2019-2024)
Figure 58. SIEMENS Revenue Growth Rate in Nuclear Medicine Business (2019-2024)
Figure 59. China Isotope & Radiation Revenue Growth Rate in Nuclear Medicine Business (2019-2024)
Figure 60. Dongcheng Revenue Growth Rate in Nuclear Medicine Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Nuclear Medicine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Tc-99
Table 3. Key Players of I-123/131
Table 4. Key Players of In-111
Table 5. Key Players of Xe-133
Table 6. Key Players of Th-201
Table 7. Key Players of Ga-67
Table 8. Key Players of Others
Table 9. Global Nuclear Medicine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Nuclear Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Nuclear Medicine Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global Nuclear Medicine Market Share by Region (2019-2024)
Table 13. Global Nuclear Medicine Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global Nuclear Medicine Market Share by Region (2025-2030)
Table 15. Nuclear Medicine Market Trends
Table 16. Nuclear Medicine Market Drivers
Table 17. Nuclear Medicine Market Challenges
Table 18. Nuclear Medicine Market Restraints
Table 19. Global Nuclear Medicine Revenue by Players (2019-2024) & (US$ Million)
Table 20. Global Nuclear Medicine Market Share by Players (2019-2024)
Table 21. Global Top Nuclear Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine as of 2023)
Table 22. Ranking of Global Top Nuclear Medicine Companies by Revenue (US$ Million) in 2023
Table 23. Global 5 Largest Players Market Share by Nuclear Medicine Revenue (CR5 and HHI) & (2019-2024)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Nuclear Medicine Product Solution and Service
Table 26. Date of Enter into Nuclear Medicine Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Nuclear Medicine Market Size by Type (2019-2024) & (US$ Million)
Table 29. Global Nuclear Medicine Revenue Market Share by Type (2019-2024)
Table 30. Global Nuclear Medicine Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 31. Global Nuclear Medicine Revenue Market Share by Type (2025-2030)
Table 32. Global Nuclear Medicine Market Size by Application (2019-2024) & (US$ Million)
Table 33. Global Nuclear Medicine Revenue Market Share by Application (2019-2024)
Table 34. Global Nuclear Medicine Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 35. Global Nuclear Medicine Revenue Market Share by Application (2025-2030)
Table 36. North America Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Nuclear Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Nuclear Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Europe Nuclear Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 41. Europe Nuclear Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 42. Asia-Pacific Nuclear Medicine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 43. Asia-Pacific Nuclear Medicine Market Size by Region (2019-2024) & (US$ Million)
Table 44. Asia-Pacific Nuclear Medicine Market Size by Region (2025-2030) & (US$ Million)
Table 45. Latin America Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Latin America Nuclear Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 47. Latin America Nuclear Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 48. Middle East & Africa Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 49. Middle East & Africa Nuclear Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 50. Middle East & Africa Nuclear Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 51. GE Healthcare Company Detail
Table 52. GE Healthcare Business Overview
Table 53. GE Healthcare Nuclear Medicine Product
Table 54. GE Healthcare Revenue in Nuclear Medicine Business (2019-2024) & (US$ Million)
Table 55. GE Healthcare Recent Development
Table 56. Bracco Imaging Company Detail
Table 57. Bracco Imaging Business Overview
Table 58. Bracco Imaging Nuclear Medicine Product
Table 59. Bracco Imaging Revenue in Nuclear Medicine Business (2019-2024) & (US$ Million)
Table 60. Bracco Imaging Recent Development
Table 61. Mallinckrodt Company Detail
Table 62. Mallinckrodt Business Overview
Table 63. Mallinckrodt Nuclear Medicine Product
Table 64. Mallinckrodt Revenue in Nuclear Medicine Business (2019-2024) & (US$ Million)
Table 65. Mallinckrodt Recent Development
Table 66. Lantheus Medical Imaging Company Detail
Table 67. Lantheus Medical Imaging Business Overview
Table 68. Lantheus Medical Imaging Nuclear Medicine Product
Table 69. Lantheus Medical Imaging Revenue in Nuclear Medicine Business (2019-2024) & (US$ Million)
Table 70. Lantheus Medical Imaging Recent Development
Table 71. Bayer Company Detail
Table 72. Bayer Business Overview
Table 73. Bayer Nuclear Medicine Product
Table 74. Bayer Revenue in Nuclear Medicine Business (2019-2024) & (US$ Million)
Table 75. Bayer Recent Development
Table 76. Triad Isotopes Company Detail
Table 77. Triad Isotopes Business Overview
Table 78. Triad Isotopes Nuclear Medicine Product
Table 79. Triad Isotopes Revenue in Nuclear Medicine Business (2019-2024) & (US$ Million)
Table 80. Triad Isotopes Recent Development
Table 81. Nordion Company Detail
Table 82. Nordion Business Overview
Table 83. Nordion Nuclear Medicine Product
Table 84. Nordion Revenue in Nuclear Medicine Business (2019-2024) & (US$ Million)
Table 85. Nordion Recent Development
Table 86. Jubilant Pharma Company Detail
Table 87. Jubilant Pharma Business Overview
Table 88. Jubilant Pharma Nuclear Medicine Product
Table 89. Jubilant Pharma Revenue in Nuclear Medicine Business (2019-2024) & (US$ Million)
Table 90. Jubilant Pharma Recent Development
Table 91. Eli Lilly Company Detail
Table 92. Eli Lilly Business Overview
Table 93. Eli Lilly Nuclear Medicine Product
Table 94. Eli Lilly Revenue in Nuclear Medicine Business (2019-2024) & (US$ Million)
Table 95. Eli Lilly Recent Development
Table 96. SIEMENS Company Detail
Table 97. SIEMENS Business Overview
Table 98. SIEMENS Nuclear Medicine Product
Table 99. SIEMENS Revenue in Nuclear Medicine Business (2019-2024) & (US$ Million)
Table 100. SIEMENS Recent Development
Table 101. China Isotope & Radiation Company Detail
Table 102. China Isotope & Radiation Business Overview
Table 103. China Isotope & Radiation Nuclear Medicine Product
Table 104. China Isotope & Radiation Revenue in Nuclear Medicine Business (2019-2024) & (US$ Million)
Table 105. China Isotope & Radiation Recent Development
Table 106. Dongcheng Company Detail
Table 107. Dongcheng Business Overview
Table 108. Dongcheng Nuclear Medicine Product
Table 109. Dongcheng Revenue in Nuclear Medicine Business (2019-2024) & (US$ Million)
Table 110. Dongcheng Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nuclear Medicine Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Nuclear Medicine Market Share by Type: 2023 VS 2030
Figure 3. Tc-99 Features
Figure 4. I-123/131 Features
Figure 5. In-111 Features
Figure 6. Xe-133 Features
Figure 7. Th-201 Features
Figure 8. Ga-67 Features
Figure 9. Others Features
Figure 10. Global Nuclear Medicine Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Nuclear Medicine Market Share by Application: 2023 VS 2030
Figure 12. Diagnostic Case Studies
Figure 13. Therapeutic Case Studies
Figure 14. Nuclear Medicine Report Years Considered
Figure 15. Global Nuclear Medicine Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Nuclear Medicine Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Nuclear Medicine Market Share by Region: 2023 VS 2030
Figure 18. Global Nuclear Medicine Market Share by Players in 2023
Figure 19. Global Top Nuclear Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Nuclear Medicine Revenue in 2023
Figure 21. North America Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Nuclear Medicine Market Share by Country (2019-2030)
Figure 23. United States Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Nuclear Medicine Market Share by Country (2019-2030)
Figure 27. Germany Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Nuclear Medicine Market Share by Region (2019-2030)
Figure 35. China Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Nuclear Medicine Market Share by Country (2019-2030)
Figure 43. Mexico Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Nuclear Medicine Market Share by Country (2019-2030)
Figure 47. Turkey Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. GE Healthcare Revenue Growth Rate in Nuclear Medicine Business (2019-2024)
Figure 50. Bracco Imaging Revenue Growth Rate in Nuclear Medicine Business (2019-2024)
Figure 51. Mallinckrodt Revenue Growth Rate in Nuclear Medicine Business (2019-2024)
Figure 52. Lantheus Medical Imaging Revenue Growth Rate in Nuclear Medicine Business (2019-2024)
Figure 53. Bayer Revenue Growth Rate in Nuclear Medicine Business (2019-2024)
Figure 54. Triad Isotopes Revenue Growth Rate in Nuclear Medicine Business (2019-2024)
Figure 55. Nordion Revenue Growth Rate in Nuclear Medicine Business (2019-2024)
Figure 56. Jubilant Pharma Revenue Growth Rate in Nuclear Medicine Business (2019-2024)
Figure 57. Eli Lilly Revenue Growth Rate in Nuclear Medicine Business (2019-2024)
Figure 58. SIEMENS Revenue Growth Rate in Nuclear Medicine Business (2019-2024)
Figure 59. China Isotope & Radiation Revenue Growth Rate in Nuclear Medicine Business (2019-2024)
Figure 60. Dongcheng Revenue Growth Rate in Nuclear Medicine Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232